Dan Passeri

Company: Cue Biopharma

Job title: President & Chief Executive Officer

Bio:

Dan Passeri, CEO of Cue Biopharma is a seasoned biotechnology executive with over 20 years of experience managing drug discovery and development programs as well as business development activities on behalf of publicly traded companies, with deep experience in both oncology and strategic partnership generation. He previously served as President, CEO, and Vice Chairman of Curis, Inc., and held senior roles at GeneLogic and Boehringer Mannheim. Dan holds a J.D. from George Washington University, an M.Sc. in Biotechnology from Imperial College London, and a B.S. in Biology from Northeastern University. 

Seminars:

Unlocking New Immune Pathways: Discussing B-Cell Depletion & Beyond in Autoimmune Therapy 9:10 am

Discussing the latest B-cell depletion data across diseases to assess effectiveness and potential for expansion into dermatological diseases such as psoriasis Evaluating if B-cell depletion remains the most promising approach and exploring the potential to move beyond B-cell targeting (including, Mast Cells, T-cells, Macrophages, Myeloid Cells and more) Exploring immune cell depletion across disease indications…Read more

day: Day Two